Abundant data have incriminated intestinal bacteria in the initiation and amplification stages of inflammatory bowel diseases (IBD). One theory has suggested a breakdown in the balance between putative species of “protective” versus “harmful” intestinal bacteria—this concept has been termed “dysbiosis”. Dysbiosis is the disruption of the normal balance of the trillions of microorganisms that populate the human intestinal tract. Those organisms occur in large communities, each of which should be as diverse as possible. Recent studies show that the greater the overall diversity among bacterial groups, the healthier the individual.
Gut dysbiosis can lead to physiological changes in the intestinal environment, disrupting the functions of the gut microbiota, autoimmune, allergic, metabolic and alcoholic liver diseases, irritable bowel syndrome, colorectal cancer, and bacterial infections have all been linked to dysbiosis. Gluten sensitivity is a result of dysbiosis not a genetic disorder. Dysbiosis (also called dysbacteriosis) refers to a condition with microbial imbalances on or within the body. Dysbiosis is most prominent in the digestive tract or on the skin, but can also occur on any exposed surface or mucous membrane such as the vagina, lungs, mouth, nose, sinuses, ears, nails, or eyes. It has been associated with different illnesses, like inflammatory bowel disease and chronic fatigue syndrome (5).
Panaxea’s DYSBIOSIS formula addresses one of the major underlying processes behind irritable bowel syndrome symptoms. The great blend of botanicals reverses dysbiosis, the fifth leading contributor to irritable bowel syndrome symptoms.
These statements have not been evaluated by the Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure or prevent any disease